Skip to content

Butyrate

DIETARY_SUPPLEMENT12 trials

Sponsors

Maastricht University Medical Center, Federico II University, KU Leuven, University of Padova, Children's Hospital Los Angeles

Conditions

EmotionsFearInflammatory Bowel DiseasesInsulin ResistanceIrritable Bowel SyndromeObesityObesity &Amp; OverweightObesity, Childhood

Phase 2

Unknown Phase

The Effects of Butyrate Enemas on Visceral Perception
CompletedNCT00726817
Maastricht University Medical CenterVisceral (Hyper)Sensitivity
Start: 2007-12-31Updated: 2017-02-24
*Effects of Butyrate on Intestinal permeability & inflammation, Intellectual performance, Immune activation and systemic Inflammation in renal disease.
NL-OMON43237
Academisch Medisch Centrumchronic kidney disease Renal failure
Target: 30Updated: 2024-02-28
Effects of Butyrate Against Pediatric Obesity
CompletedNCT04620057
Federico II UniversityObesity, Childhood
Start: 2020-11-01End: 2021-12-31Updated: 2022-04-08
Effects of Butyrate on Affective Processes
CompletedNCT04722549
KU LeuvenEmotions, Fear, Stress
Start: 2021-02-08End: 2022-12-11Updated: 2023-01-04
Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease
CompletedNCT04879914
University of PadovaInflammatory Bowel Diseases, Irritable Bowel Syndrome
Start: 2020-06-01End: 2022-09-30Updated: 2022-11-03
Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders
CompletedNCT05718583
NYU Langone HealthRheumatoid Arthritis
Start: 2023-02-01End: 2025-02-20Updated: 2026-09-02
Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders
Active, not recruitingNCT07180446
Texas Christian UniversityObesity &Amp; Overweight
Start: 2026-01-18End: 2026-06-30Target: 40Updated: 2026-05-27
Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease
RecruitingNCT07591012
University of PadovaUlcerative Colitis (Disorder)
Start: 2026-05-01End: 2027-03-30Target: 40Updated: 2026-05-15
Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingNCT07684248
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludType 1 Diabetes
Start: 2026-09-15End: 2028-02-15Target: 200Updated: 2026-07-06

Related Papers